ANNOUNCEMENT

MedCity CONVERGE July 9-10 in Philly gathers payers, providers, medtech, pharma, digital health, policymakers & more.

Topic: Delaware

Skepticism greets AstraZeneca in second round of changes announced this week

Skepticism greets AstraZeneca in second round of changes announced this week

March 22, 2013 8:54 am by | 0 Comments

In AstraZeneca’s (NYSE: AZN) statement outlining additional changes the drug maker will make to its global business to achieve scientific leadership this week, it underscored the magnitude with a few ... Read more
AstraZeneca shakes up R&D division with 1,600 staff cuts and shift to biotech hot spots (video)

AstraZeneca shakes up R&D division with 1,600 staff cuts and shift to biotech hot spots (video)

March 18, 2013 12:15 pm by | 1 Comments

AstraZeneca (NYSE:AZN) is revamping its research and development divisions to improve drug development by cutting 1,600 from its global operations and focusing R&D staff in three sites including Gaithersburg, Maryland. ... Read more
iBio’s technology that tricks plants into producing human protein at the center of collaboration agreement

iBio’s technology that tricks plants into producing human protein at the center of collaboration agreement

February 19, 2013 6:37 pm by | 0 Comments

Biotechnology company iBio (NYSE MKT: IBIO) with a plant-based platform to develop vaccines and therapeutics has formalized a collaboration agreement with a Texas-based life science company. A previous iteration of ... Read more
Artificial salivary gland project to aid throat cancer patients

Artificial salivary gland project to aid throat cancer patients

August 13, 2012 3:13 pm by | 0 Comments

Research to develop artificial salivary glands to facilitate swallowing for throat cancer patients has brought a Delaware health system’s cancer research center a $2.5 million grant from the National Institutes ... Read more
Another amazing example of the potential of 3D printing in healthcare (video)

Another amazing example of the potential of 3D printing in healthcare (video)

August 4, 2012 7:56 am by | 0 Comments

A heartwarming new video documents the story of a small child whose life has been radically changed for the better because of 3D printing technology.Two-year-old Emma was born with a ... Read more
Which states are opting in or out of Medicaid expansion with Affordable Care Act? (infographic)

Which states are opting in or out of Medicaid expansion with Affordable Care Act? (infographic)

July 6, 2012 1:56 pm by | 0 Comments

With my ears still ringing from July 4 fireworks, I was drawn to the handy infographic mapping out states’ positions on expanding their Medicaid programs for low-income residents to comply ... Read more
Lilly’s rheumatoid arthritis drug using JAK inhibitors gets positive 2b results

Lilly’s rheumatoid arthritis drug using JAK inhibitors gets positive 2b results

June 8, 2012 3:11 pm by | 0 Comments

Eli Lilly‘s (NYSE:LLY) rheumatoid arthritis treatment developed by drug developer Incyte (NASDAQ:INCY) using oral janus-associated kinases, or JAK, inhibitors, has produced positive phase 2b results, according to a company statement.The ... Read more
EU recommendation triggers $40M milestone payment for bone marrow disease drug

EU recommendation triggers $40M milestone payment for bone marrow disease drug

April 20, 2012 2:01 pm by | 0 Comments

A European Union regulatory committee’s recommendation to approve a drug developed by Incyte (NASDAQ:INCY) to treat the bone marrow disease myelofibrosis has triggered a $40 million milestone payment from Novartis ... Read more
AstraZeneca and Amgen collaborate on treatments for inflammatory diseases

AstraZeneca and Amgen collaborate on treatments for inflammatory diseases

April 2, 2012 8:08 pm by | 0 Comments

AstraZeneca (NYSE:AZN) and Amgen (NYSE:AMGN) will collaborate on five monoclonal antibodies to treat inflammatory diseases in a move that could help AstraZeneca steer away from the patent cliff and put ... Read more
Hospital marketers branch out to Yammer and Tumblr to reach patients

Hospital marketers branch out to Yammer and Tumblr to reach patients

February 27, 2012 8:00 am by | 0 Comments

Started in 2008 by one of the co-founders of PayPal, Yammer is a behind-the-firewall, institutional version of Facebook and has developed a base of 1,500 healthcare institutions and biotech companies ... Read more
Big Pharma shrink continues with more AstraZeneca job cuts

Big Pharma shrink continues with more AstraZeneca job cuts

February 2, 2012 2:19 pm by | 0 Comments

AstraZeneca (NYSE:AZN) is cutting more than 7,300 jobs across its global operations as part of a restructuring move the pharmaceutical giant announced in its fourth-quarter earnings for 2012.A spokesman for ... Read more
FDA rejects diabetes drug from Bristol-Myers Squibb, AstraZeneca

FDA rejects diabetes drug from Bristol-Myers Squibb, AstraZeneca

January 19, 2012 8:58 am by | 0 Comments

Bristol-Myers Squibb (NYSE:BMY) and AstraZeneca’s (NYSE:AZN) jointly developed treatment for type 2 diabetes has been turned down by U.S. regulators until lingering questions over the diabetes drug’s benefits and risks ... Read more
iBio seeks to raise $10 million for plant-based vaccine production

iBio seeks to raise $10 million for plant-based vaccine production

January 10, 2012 12:40 pm by | 0 Comments

iBio (NYSE:IBIO) is seeking to raise $10 million for its plant-based vaccine production in a public offering.The Newark, Delaware-based pharmaceutical company has priced 15,385,000 units at 65 cents per unit.Each ... Read more
Antarctic research scientists raise $600K for gene discovery software firm

Antarctic research scientists raise $600K for gene discovery software firm

December 13, 2011 11:38 am by | 0 Comments

Evozym Biologics, founded in 2009 by Antarctic research scientists at the University of Delaware and the Desert Research Institute, has raised $600,000 to fund business development and strategic partnerships for ... Read more
FDA approval for Incyte drug could pave way for JAK inhibitors

FDA approval for Incyte drug could pave way for JAK inhibitors

November 17, 2011 4:41 pm by | 0 Comments

Incyte (NASDAQ:INCY), a Wilmington, Delaware-based biotechnology company has received approval from the U.S. Food and Drug Administration for its drug Jakafi, the first approved drug to treat myelofibrosis, a bone ... Read more